Brief: Lyra Therapeutics Posts Quarterly Loss Per Share Of $0.85

Lyra Therapeutics

09/11/2021 23:05

Nov 9 (Reuters) - Lyra Therapeutics Inc  LYRA.O :
    * LYRA THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * LYRA THERAPEUTICS INC - EXPECTS ITS CASH BALANCE TO BE
SUFFICIENT TO FUND ITS PLANNED OPERATIONS THROUGH 2022
    * LYRA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.85

Source text for Eikon:  ID:nPn5RMhn0a 
Further company coverage:  LYRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))